Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 280 | 645 | 466 | 702 | 448 |
| Receivables | 6 | 4 | 1 | 12 | N/A |
| TOTAL | $1,747 | $2,453 | $1,187 | $1,725 | $1,829 |
| Non-Current Assets | |||||
| Intangibles | 705 | 738 | 771 | 804 | 837 |
| Other Non-Current Assets | 10,079 | 50 | 50 | 50 | 50 |
| TOTAL | $10,784 | $788 | $821 | $854 | $887 |
| Total Assets | $12,531 | $3,241 | $2,008 | $2,579 | $2,716 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,406 | 1,175 | 851 | 751 | 1,166 |
| Other current liabilities | 21,119 | 8,903 | 7,958 | 8,334 | 8,933 |
| TOTAL | $22,525 | $10,078 | $8,809 | $9,085 | $10,099 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 10,011 | 10,536 | 8,349 | 6,756 | 4,209 |
| TOTAL | $10,011 | $10,478 | $8,348 | $6,756 | $4,208 |
| Total Liabilities | $32,536 | $20,556 | $17,157 | $15,841 | $14,307 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,078 | 1,078 | 1,078 | 1,078 | 1,078 |
| Common Shares | 4 | N/A | 4 | 4 | 4 |
| Retained earnings | -119,487 | -116,210 | -113,507 | -111,072 | -108,454 |
| Other shareholders' equity | -111 | -103 | -45 | -44 | -44 |
| TOTAL | $-20,005 | $-17,315 | $-15,149 | $-13,262 | $-11,591 |
| Total Liabilities And Equity | $12,531 | $3,241 | $2,008 | $2,579 | $2,716 |